相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OTUD5 promotes innate antiviral and antitumor immunity through deubiquitinating and stabilizing STING
Yunyun Guo et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Deubiquitinase OTUD5 is a positive regulator of mTORC1 and mTORC2 signaling pathways
Jin Hwa Cho et al.
CELL DEATH AND DIFFERENTIATION (2021)
mTOR at the nexus of nutrition, growth, ageing and disease
Grace Y. Liu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB
Yizhong Ji et al.
CELLULAR SIGNALLING (2020)
Control of mTOR signaling by ubiquitin
Yao Jiang et al.
ONCOGENE (2019)
The deubiquitinase OTUD5 regulates Ku80 stability and non-homologous end joining
Fangzhou Li et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
Targeting mTOR for cancer therapy
Hui Hua et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
The RING-type E3 ligase RNF186 ubiquitinates Sestrin-2 and thereby controls nutrient sensing
Travis B. Lear et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
The OTUD5-UBR5 complex regulates FACT-mediated transcription at damaged chromatin
Angelo de Vivo et al.
NUCLEIC ACIDS RESEARCH (2019)
OTUB1 protein suppresses mTOR complex 1 (mTORC1) activity by deubiquitinating the mTORC1 inhibitor DEPTOR
Linlin Zhao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Everolimus Inhibits Growth of Gemcitabine-Resistant Pancreatic Cancer Cells via Induction of Caspase-Dependent Apoptosis and G2/M Arrest
Tao Peng et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2017)
mTORC1 signaling and the metabolic control of cell growth
Issam Ben-Sahra et al.
CURRENT OPINION IN CELL BIOLOGY (2017)
METABOLISM Sestrin2 is a leucine sensor for the mTORC1 pathway
Rachel L. Wolfson et al.
SCIENCE (2016)
Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise
Jaegil Kim et al.
CLINICAL CANCER RESEARCH (2015)
Cellular and molecular effects of the mTOR inhibitor everolimus
Uttara Saran et al.
CLINICAL SCIENCE (2015)
mTOR: a pharmacologic target for autophagy regulation
Young Chul Kim et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Sestrin2 integrates Akt and mTOR signaling to protect cells against energetic stress-induced death
I. Ben-Sahra et al.
CELL DEATH AND DIFFERENTIATION (2013)
A novel RING finger E3 ligase RNF186 regulate ER stress-mediated apoptosis through interaction with BNip1
Peng Wang et al.
CELLULAR SIGNALLING (2013)
Everolimus in colorectal cancer
Ivy Altomare et al.
EXPERT OPINION ON PHARMACOTHERAPY (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Ubiquitin-specific Peptidase 9, X-linked (USP9X) Modulates Activity of Mammalian Target of Rapamycin (mTOR)
Pooja Agrawal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Effects of mTOR Inhibitor Everolimus (RAD001) on Bladder Cancer Cells
Edmund Chiong et al.
CLINICAL CANCER RESEARCH (2011)
DEPTOR, an mTOR Inhibitor, Is a Physiological Substrate of SCFβTrCP E3 Ubiquitin Ligase and Regulates Survival and Autophagy
Yongchao Zhao et al.
MOLECULAR CELL (2011)
mTOR Generates an Auto-Amplification Loop by Triggering the βTrCP- and CK1α-Dependent Degradation of DEPTOR
Shanshan Duan et al.
MOLECULAR CELL (2011)
mTOR Drives Its Own Activation via SCFβTrCP-Dependent Degradation of the mTOR Inhibitor DEPTOR
Daming Gao et al.
MOLECULAR CELL (2011)
p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling
Andrei V. Budanov et al.
CELL (2008)
FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression
Jian-Hua Mao et al.
SCIENCE (2008)
DUBA: A deubiquitinase that regulates type I interferon production
Nobuhiko Kayagaki et al.
SCIENCE (2007)
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2007)
分享论文
